NCT07740278 3D Printing Orientation and Film Thickness for Maxillary Complete Dentures
| NCT ID | NCT07740278 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Complete Edentulism |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-08-08 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-08-08 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized crossover clinical trial aims to evaluate the effect of different three-dimensional (3D) printing orientations and layer thicknesses on the trueness, dimensional accuracy, and patient satisfaction of maxillary complete dentures in completely edentulous patients. Each participant will receive two maxillary 3D-printed complete dentures fabricated using the same printing orientation (0°, 45°, or 90°) with two different layer thicknesses (50 μm and 100 μm) in a crossover sequence. The study will compare the influence of these printing parameters on denture accuracy and patient-reported outcomes to identify the optimal 3D printing settings for complete denture fabrication.
Eligibility Criteria
Inclusion Criteria: 1. Completely edentulous patients with good local and systemic health. 2. Patients age ranging from 50 to 70 years old. 3. Patients with adequate inter-arch space. 4. Patients with good neuromuscular control. Exclusion Criteria: 1. Patients with any oral diseases which may affect denture construction 2. Patients with oral parafunctional habits. 3. Patients with tempro-mandibular disorders
Contact & Investigator
noha Mamdouh Hamed elkafoury, BDS, MSc
PRINCIPAL INVESTIGATOR
Faculty of Dentistry, Tanta University, Egypt
Frequently Asked Questions
Who can join the NCT07740278 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 70 Years, studying Complete Edentulism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07740278 currently recruiting?
Yes, NCT07740278 is actively recruiting participants. Contact the research team at nohaelkafoury@dent.tanta.edu.eg for enrollment information.
Where is the NCT07740278 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07740278 clinical trial?
NCT07740278 is sponsored by Tanta University. The principal investigator is noha Mamdouh Hamed elkafoury, BDS, MSc at Faculty of Dentistry, Tanta University, Egypt. The trial plans to enroll 15 participants.